Federation Des Caisses Desjardins Du Quebec Lantern Pharma Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $21.3 Billion
- Q2 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 800 shares of LTRN stock, worth $3,511. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800Holding current value
$3,511% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LTRN
# of Institutions
37Shares Held
2.22MCall Options Held
16.4KPut Options Held
0-
Bios Capital Management, LP Fort Worth, TX1.08MShares$4.72 Million4.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.6 Million0.0% of portfolio
-
Cm Management, LLC200KShares$877,9990.65% of portfolio
-
Geode Capital Management, LLC Boston, MA91.9KShares$403,4010.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny90.6KShares$397,7340.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $47.5M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...